Budesonide-Formoterol
- Generic Name
- Budesonide-Formoterol
- Indication
用于支气管哮喘，主要用于慢性持续性支气管哮喘；也可在重度慢性阻塞性肺疾病使用。
Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients.
Not Applicable
Recruiting
- Conditions
- Cough-Variant Asthma
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1000
- Registration Number
- NCT06590740
- Locations
- 🇨🇳
Research Site, Zunyi, China
Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy
Phase 4
Not yet recruiting
- Conditions
- Bronchial Asthma
- Interventions
- Drug: Maintenance at initial treatment sequential as-needed therapy with inhaled budesonide-formoterol(Symbicort 160/4.5) ®）
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Target Recruit Count
- 90
- Registration Number
- NCT06568445
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai, Shanghai, China
Replication of the D58 Asthma Trial in Healthcare Claims Data
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 66581
- Registration Number
- NCT04892732
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway
Terminated
- Conditions
- AsthmaCOPD
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 29
- Registration Number
- NCT04663386
- Locations
- 🇳🇴
Flattum Legesenter, Hønefoss, Norway
Efficacy of Budesonide-Formoterol in Bronchiectasis
Not Applicable
Completed
- Conditions
- Bronchiectasis
- Interventions
- First Posted Date
- 2008-08-06
- Last Posted Date
- 2008-08-06
- Lead Sponsor
- Hospital General de Requena
- Target Recruit Count
- 40
- Registration Number
- NCT00728715
- Locations
- 🇪🇸
Hospital General de Requena, Valencia, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath